Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1148/radiol.2313030173
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pijl, M. E. J.
Right arrow Articles by Bloem, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pijl, M. E. J.
Right arrow Articles by Bloem, J. L.
(Radiology 2004;231:737-744.)
© RSNA, 2004


Special Report

Quantitative Analysis of Focal Masses at MR Imaging: A Plea for Standardization1

Milan E. J. Pijl, MD, Joost Doornbos, PhD, Martin N. J. M. Wasser, MD, Hans C. van Houwelingen, PhD, Rob A. E. M. Tollenaar, MD and Johan L. Bloem, MD

1 From the Departments of Radiology (M.E.J.P., J.D., M.N.J.M.W., J.L.B.), Medical Statistics (H.C.v.H.), and Surgery (R.A.E.M.T.), Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, the Netherlands. Received February 3, 2003; revision requested April 22; final revision received November 9; accepted November 10. Address correspondence to M.E.J.P. (e-mail: m.e.j.pijl@lumc.nl).

PURPOSE: To assess the effects of changing analytic method variables on the signal intensity (SI) difference–to-noise ratios (SDNRs) for the contrast between lesions and background organs depicted on magnetic resonance (MR) images and to propose a standardized analytic method for the quantitative analysis of focal masses seen at MR imaging.

MATERIALS AND METHODS: The SIs of 48 liver metastases (originating from colorectal cancer) in 20 patients, the surrounding liver parenchyma, and the background noise were measured on T2-weighted MR images. All 2000 and 2001 issues of the American Journal of Roentgenology, the Journal of Magnetic Resonance Imaging, Magnetic Resonance Imaging, and Radiology were searched for articles describing quantitative analyses. SDNRs were calculated by using formulas from these articles and various region-of-interest (ROI) locations to measure metastasis and background noise SIs. The Wilcoxon signed rank test was used to compare the various SDNR calculations.

RESULTS: In 34 articles in which quantitative analyses of focal masses are described, the reported SDNRs were calculated with four different formulas. The SDNRs for our study material calculated with the four formulas reported in the literature differed grossly in both number and unit. The SDNRs for ROIs encompassing the entire metastasis differed significantly (P = .034) from the SDNRs for ROIs in a homogeneous area of the metastasis margin. Differences in SDNRs between various noise ROI locations were significant (P < .022).

CONCLUSION: Slight changes in the variables of quantitative analysis of focal masses had marked effects on reported SDNRs. To overcome these effects, the use of a standardized method involving one formula, a lesion ROI in a homogeneous area at the metastasis margin, and a background noise ROI along the phase-encoding axis in the air (including systematic noise) is proposed for the quantitative analysis of findings on magnitude MR images.

© RSNA, 2004

Index terms: Data analysis • Liver neoplasms, 75.33, 76.32, 76.33 • Liver neoplasms, metastases, 75.33, 76.33 • Liver neoplasms, MR, 76.121411, 76.121416, 76.12146 • Magnetic resonance (MR), tissue characterization, 76.12146




This article has been cited by other articles:


Home page
JCOHome page
A. B. Siegel, E. I. Cohen, A. Ocean, D. Lehrer, A. Goldenberg, J. J. Knox, H. Chen, S. Clark-Garvey, A. Weinberg, J. Mandeli, et al.
Phase II Trial Evaluating the Clinical and Biologic Effects of Bevacizumab in Unresectable Hepatocellular Carcinoma
J. Clin. Oncol., June 20, 2008; 26(18): 2992 - 2998.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Radiol.Home page
D P O'Regan, J Fitzgerald, J Allsop, D Gibson, D J Larkman, D Cokkinos, J V Hajnal, and S A Schmitz
A comparison of MR cholangiopancreatography at 1.5 and 3.0 Tesla
Br. J. Radiol., October 1, 2005; 78(934): 894 - 898.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
E. M. Merkle, S. G. Nour, and J. S. Lewin
MR Imaging Follow-up after Percutaneous Radiofrequency Ablation of Renal Cell Carcinoma: Findings in 18 Patients during First 6 Months
Radiology, June 1, 2005; 235(3): 1065 - 1071.
[Abstract] [Full Text] [PDF]